Nephrotoxicity pp 383-388 | Cite as

Drug Pharmacokinetics in Renal Failure — Influence of Disease Type

  • Amor Maiza
  • Peter T. Daley-Yates


For many drugs the major route of elimination from the body is renal excretion. Therefore, a loss of renal function will lead to excessive accumulation of the drug or its metabolites in the body, unless the drug dosage is reduced. The problem is particularly acute for drugs that have a narrow therapeutic index intended for patients with severe renal insufficiency. A failure to appropriately adjust dosage can lead to toxicity, which for some drugs may be life-threatening.


Toxicity Catheter Mercury Creatinine Paraffin 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Fabre, J. and Balant, L. Renal failure, drug pharmacokinetics and drug action.Clin. Pharmacol., 1:99–120 (1976).CrossRefGoogle Scholar
  2. 2.
    Dettli, L. Drug dosage in renal disease.Clin. Pharmacol., 1:126–134 (1976).CrossRefGoogle Scholar
  3. 3.
    Burton, M.W., Vasko, M.R. and Brattier, D.C. Comparison of drug dosing methods.Clin. Pharmacol., 10:1–37 (1985).CrossRefGoogle Scholar
  4. 4.
    Welling, P.G., Craig, W.A. and Kunin, M.C. Prediction of drug dosage in patients with renal failure using data derived from normal subjects.Clin. Pharmacol. Therap., 18:45–52 (1975).Google Scholar
  5. 5.
    Bricker, N.S., Morrin, P.A.F. and Kime, S.W. The pathologic physiology of chronic Bright‚ s disease.Am. J. Med., 28:77–98 (1960).PubMedCrossRefGoogle Scholar
  6. 6.
    Bricker, N.S. Klahr, S., Lubowitz, H. and Rieselbach, R.E. Renal function in chronic renal disease.Medicine 44:263–288 (1965).PubMedCrossRefGoogle Scholar
  7. 7.
    Cottier, P. and Haldemann, G. De l‚emploi d‚un Sulfamide (Ro — 4393) a duree d‚action prolongee dans le traitement de la pyelonephrite chronique.J. d‚Urol. Nephrol., 70:797–809 (1964).Google Scholar
  8. 8.
    Williams, O.M., Wimpenny, J. and Asscher, A.W. Renal clearance of sodium sulphadimidine in normal and uraemic subjects.Lancet 2:1058–1060 (1968).PubMedCrossRefGoogle Scholar
  9. 9.
    Petipierre, B., Perrin, L., Rudhardt, M., Herrera, A. and Fabre, J. Behaviour of chlorpropamide in renal insufficiency and under the effect of associated drug therapy.Int. J. Clin. Pharmacol., 6:120 (1972).Google Scholar
  10. 10.
    Shim, C. K., Sawada, Y., Iga, T. and Hanano, M. Estimation of renal secretory function for organic cations by endogenous N-methylnicotinamide in rats with experimental renal failure.J. Pharmaco. Biopharm., 12:23–42 (1984).CrossRefGoogle Scholar
  11. 11.
    Giacomini, K.M., Roberts, S.M. and Levy, G. Evaluation of methods for producing renal dysfunction in rats.J. Pharm. Sci., 70:117–121 (1981)PubMedCrossRefGoogle Scholar
  12. 12.
    Daley-Yates, P.T. and McBrien, D.C.H. Cisplatin nephrotoxicity. In: Nephrotoxicity, Assessment and Pathogenesis (eds. P.H. Bach, F.W. Bonner, J.W. Bridges and E.A. Lock), pp 358–370. John Wiley & Sons, Chichester (1982).Google Scholar
  13. 13.
    Hill, G.S., Willye, R.G., Miller, M. and Heptinstall, R.M. Experimental papillary necrosis of the kidney.Am. J. Pathol. 68:213 (1972).PubMedGoogle Scholar
  14. 14.
    Nagi, A.H., Alexander, F. and Barabas, A.Z. Gold nephropathy in rats — Light and electron microscopic studies.Exp. Mol. Pathol., 15:354 (1971).PubMedCrossRefGoogle Scholar
  15. 15.
    Fiegelson, E.B., Drake, J.W. and Recant, L., Experimental aminonucleoside nephrosis in rats.J. Lab. Clin. Med. 50:437 (1957).PubMedGoogle Scholar
  16. 16.
    Stitzer, S.O. and Maldonado M.M., Clearance methods in the rat. In: Methods in Pharmacology, Vol 2 (ed. M.M. Maldonado) , pp 23–40. Plenum Press, New York (1978).Google Scholar
  17. 17.
    Biber, T. U. L., Mylle, M., Baines, A.D., Gottschalk, C. W., Oliver, J.R. and MacDowell, M.C. A study by micropuncture and microdissection of acute renal damage in rats.Amer. J. Med. 44:664–705 (1968).PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1989

Authors and Affiliations

  • Amor Maiza
    • 1
  • Peter T. Daley-Yates
    • 1
  1. 1.Department of PharmacyUniversity of ManchesterManchesterUK

Personalised recommendations